📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
NOVELIX PHARMACEUTICALS LIMITEDNOVELIXPharmacy Retail
Open
58
High
58
Low
51.5
Close
53.08
Volume
7971
Exchange
bse
Time
21-May-2026

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Novelix Pharmaceuticals is  
Long Body
Estimated Stoploss of Novelix Pharmaceuticals is ₹  
58
Novelix Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Novelix Pharmaceuticals maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Novelix Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Novelix Pharmaceuticals is  
Downℹ
 by  

3.24

%. 
Target
Buy @ 

49.93

Sell @ 

61.51

Current @ 

53.08

Volume

Novelix Pharmaceuticals has seen a  
Significantℹ
 rise in volume of trades. 
The volume trend for Novelix Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Novelix Pharmaceuticals is  

Up

 by  

37.28

% 

Valuation

The current market price of Novelix Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 27cr and total assets worth ₹ 27cr, the balance sheet of Novelix Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Novelix Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 13cr spent in operatingℹ
7.69% i.e. ₹ 2cr earned in investingℹ
42.31% i.e. ₹ 11cr earned in financingℹ
0% in otherℹ
Income
The income of Novelix Pharmaceuticals is  

₹ 22cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

10

% 

(*Jun 2025)

The income of Novelix Pharmaceuticals is  

₹ 20cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

300

% 

(*Mar 2025)

The income of Novelix Pharmaceuticals is  

₹ 5cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Novelix Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

66.67

% 

(*Dec 2024)

Market Cap

Market capital of NOVELIX PHARMACEUTICALS LIMITED is 85cr

Top Rated Competitors

NameScore
Medplus Health Services Limited
0.5
By using this site you agree to the use of cookies to deliver a better site experience.